Siedlerstraße 7 | 68623 Lampertheim, Germany

info@zamann-pharma.com

This article explains how PSURs support regulatory assessment through structured benefit–risk evaluation, safety data integration, and inspection readiness, helping organizations maintain consistent safety reasoning and meet evolving regulatory expectations across post-marketing reporting cycles.
The pharmaceutical industry is under growing scrutiny from regulators when it comes to CAPA effectiveness checks. This blog explores how to improve root cause analysis, ensure closed-loop CAPA systems, and avoid repeat findings in GMP audits.
Prepare for a successful GMP inspection by conducting internal audits, implementing strong quality control systems, staying updated on regulations, utilizing technology, and conducting mock inspections. These steps will help pharmaceutical companies ensure compliance, uphold quality, and demonstrate commitment to patient
In the pharmaceutical industry, GMP inspections ensure quality and compliance, demonstrating commitment to safety and building trust with healthcare professionals and patients. Understanding the inspection process, guidelines, and common deficiencies is crucial for upholding industry standards and ensuring patient safety.